Related Experiment Video
Updated: May 3, 2026

06:20
Murine Bilateral Renal Lymphadenectomy
Published on: December 30, 2025
214
Bilateral renal mass-renal disorder: tuberculosis
Ozlem Tiryaki1, Celalettin Usalan1, Samet Alkan2
1Department of Nephrology, Gaziantep University School of Medicine, Gaziantep, Turkey.
Case Reports in Nephrology
|February 15, 2014
Summary
This case study highlights bilateral renal masses in a young female patient with tuberculosis and renal insufficiency. Functional imaging is critical for diagnosing renal masses in patients with new onset renal failure.
Area of Science:
- Nephrology
- Radiology
- Infectious Diseases
Background:
- New onset renal failure necessitates thorough evaluation, including renal sonography.
- Renal masses discovered during sonography require further investigation, potentially involving functional imaging.
- Tuberculosis can present with renal involvement, including renal masses.
Purpose of the Study:
- To report a rare case of bilateral renal masses in a young female patient.
- To emphasize the role of functional imaging in evaluating renal masses in renal insufficiency.
- To discuss the association between tuberculosis and renal insufficiency with bilateral renal masses.
Main Methods:
- Renal sonography was performed as part of the initial evaluation for new onset renal failure.
- Magnetic resonance (MR) imaging was utilized to further characterize the bilateral renal masses.
- Clinical presentation and diagnostic workup were reviewed.
Main Results:
- Sonography revealed bilateral renal masses in a young female patient presenting with weakness and fatigue.
- MR imaging confirmed the presence of bilateral renal masses.
- The patient was diagnosed with tuberculosis and renal insufficiency.
Conclusions:
- Bilateral renal masses can be a manifestation of tuberculosis in young females with renal insufficiency.
- Functional imaging, such as MR, plays a crucial role in the diagnosis and management of renal masses.
- Early detection and appropriate management are essential for patients with renal failure and suspected renal masses.
Related Concept Videos
Pulmonary Tuberculosis III
1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis II
2.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Pulmonary Tuberculosis IV
828
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
828
Pulmonary Tuberculosis V
1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Other Pulmonary Disorders
1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K

